Finally, no statistically significant difference was observed between ATOH1 fold change and MRF involvement (p =0.103), depth of tumor invasion (p =0.158), spread to regional LN (p =0.536) nor clinical staging (p=0.217) of rectal tumors (Table 2). Here, ATOH1 is linked to rectal neoplasm.